Fundz

Akoya Biosciences, Inc. reported raising $24.5 Million in an initial SEC Form D filing, from an offering of $25.5 Million

PRIVATEOct 02, 2018

Amount Raised

$24.5 Million

$24.5 Million sold, per SEC Form D (first sale Oct 2, 2018)

Round Type

Venture

MarlboroughOtherBiotechnologyHealth CareGeneticsHealth DiagnosticsBioinformatics

Who to call at Akoya Biosciences, and when

A new round usually means Akoya Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Akoya Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Akoya Biosciences, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Akoya Biosciences

Location

Marlborough, Massachusetts, United States

About

Akoya Biosciences is The Spatial Biology Company®, dedicated to advancing human health by providing spatial phenotyping solutions that bring biological context to life. Through comprehensive single-cell imaging technologies, Akoya enables researchers to visualize how cells are organized and interact within tissues to drive disease progression and therapeutic response. Serving discovery, translational, and clinical research, Akoya’s product portfolio includes PhenoCode™ Panels, PhenoCycler®, PhenoImager® Fusion, and PhenoImager HT Instruments—delivering powerful tools for understanding biology in spatial context.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Akoya Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Akoya Biosciences's next move

See what Strategic adds

Akoya Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.